Market News Earnings Summary: Citizens Financial Group reports Q3 2025 results 4 months ago Financial services company Citizens Financial Group, Inc. (NYSE: CFG) reported an increase in revenues and underlying earnings for the third… INFY Earnings: Infosys Q2 revenue and profit rise YoY; guides FY26 4 months ago Tech giant Infosys (NYSE: INFY) on Wednesday reported an increase in revenues and earnings for the second quarter of fiscal… Wealthfront Corporation prepares for IPO. Here’s what to expect 4 months ago The US IPO market witnessed strong activity in recent months, supported by resilient equity markets and easing concerns over interest… What to look for when Southwest Airlines (LUV) reports Q3 2025 earnings results 4 months ago Shares of Southwest Airlines Co. (NYSE: LUV) stayed green on Wednesday. The stock has dropped 10% over the past three… Earnings Summary: Synchrony Financial (SYF) Q3 2025 earnings jump 47% 4 months ago Consumer finance company Synchrony Financial (NYSE: SYF) on Wednesday announced financial results for the third quarter of fiscal 2025, reporting… Earnings Summary: Prologis reports higher revenue and a dip in profit for Q3 2025 4 months ago Real estate investment trust Prologis, Inc. (NYSE: PLD) on Wednesday reported an increase in revenues and a decline in earnings… Earnings Summary: Progressive Corporation Q3 2025 profit rises 4 months ago Insurance holding company Progressive Corporation (NYSE: PGR) reported double-digit growth in premiums and earnings for the third quarter of fiscal… United Airlines Q3 2025 Earnings: Stay tuned for the live earnings call and real-time transcript 4 months ago Aviation giant United Airlines Holdings, Inc. (NYSE: UAL) is all set to publish its third-quarter 2025 financial results today after… What to look for when Hasbro (HAS) reports Q3 2025 earnings results 4 months ago Shares of Hasbro, Inc. (NASDAQ: HAS) were up over 1% on Tuesday. The stock has gained 31% year-to-date. The toy… Kairos Pharma’s goal is to intervene early in resistance and re-sensitize cancer cells to therapy: CEO 4 months ago Kairos Pharma, Ltd. (NYSE: KAPA) is a biopharma company developing a pipeline of targeted therapies for cancer patients with high… Next» « Previous